Workplace Drug Testing in the U.S.: Market Dynamics and Emerging Trends
The U.S. employer and workplace drug testing market size is anticipated to reach USD 3.47 billion by 2030, growing at a CAGR 5.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Regulatory compliance is a significant driver for market growth. Federal regulations, such as those from the Department of Transportation (DOT) and the Substance Abuse and Mental Health Services Administration (SAMHSA), mandate testing for safety-sensitive roles to ensure workplace safety and mitigate liability risks. These regulations enforce testing across industries, especially those involving heavy machinery or transportation. In 2020, the American Public Health Association further emphasized the importance of drug testing by advocating for comprehensive strategies to address Opioid Use Disorder (OUD) and overdose risks in occupational settings. Their recommendations included strengthening injury prevention programs, addressing ergonomic risks, providing opioid mi...